𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adefovir treatment in posttransplant hepatitis B virus infection resistant to lamivudine plus hepatitis B virus immunoglobulin

✍ Scribed by S. Akay; Z. Karasu; M. Akyıldız; Y. Tokat


Book ID
116930400
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
54 KB
Volume
36
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Dynamics of lamivudine-resistant hepatit
✍ Samreen Ijaz; Catherine Arnold; Samir Dervisevic; Jana Mechurova; Nick Tatman; R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

## Abstract Adefovir dipivoxil has been used alone or together with lamivudine to suppress lamivudine‐resistant hepatitis B virus (HBV). However, the dynamics of HBV populations under different selection pressures and their impact on treatment outcome are poorly understood. Pyrosequencing® was appl

Comparison of adefovir and tenofovir in
✍ Florian van Bömmel; Thomas Wünsche; Stefan Mauss; Petra Reinke; Alexandra Bergk; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

Adefovir dipivoxil was recently approved for the treatment of wild-type and lamivudineresistant hepatitis B virus (HBV) infection. Tenofovir disoproxil fumarate, a congender of adefovir that is used in the treatment of HIV infected patients, has recently been shown to also be effective in patients w

Susceptibility of hepatitis B virus to l
✍ H.L. Zaaijer; R.B. Takkenberg; C.J. Weegink; S.P.H. Rebers; S. Menting; H.W. Ree 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

## Abstract Serial monotherapy and add‐on regimes for treatment of chronic hepatitis B virus (HBV) infection may induce the accumulation of viral resistance mutations in patients, reducing the options for ongoing viral suppression. The induction of antiviral resistance by serial application of poly